Nexavar

Latest stories

3d
The Financial Express
Govt’s pharma FDI sop may hit affordable healthcareNatco Pharma was allowed to make and sell generic version of German drugmaker B
Govt’s pharma FDI sop may hit affordable healthcare
The Financial Express / Posted 3 days ago
Natco Pharma was allowed to make and sell generic version of German drugmaker Bayer AG’s patented cancer drug Nexavar. The US and the EU have been putting pressure on India to make appropriate changes to these provisions to boost... Read more
13d
The Financial Express
Why you just can’t have a one-size-fits-all IPR policyis a crucial drug for patients suffering from kidney and liver cancer. Bayer wa
Why you just can’t have a one-size-fits-all IPR policy
The Financial Express / Posted 13 days ago
is a crucial drug for patients suffering from kidney and liver cancer. Bayer was selling the product under the brand name Nexavar for Rs 2.84 lakh per patient per month, which is unaffordable for most people in India. In 2012, the Patent... Read more
2 related stories
23d
Business Standard India
Sensex, Nifty underperform global indices; Services PMI disappointpartner, Mylan Inc., has received a tentative approval from USFDA for cancer dr
Sensex, Nifty underperform global indices; Services PMI disappoint
Business Standard India / Posted 23 days ago
partner, Mylan Inc., has received a tentative approval from USFDA for cancer drug Sorafenib, the generic version of Nexavar. Dr Reddy's Lab shed 0.5%as Mylan's US launch generic Vidaza injection is likely to increase competitive pressure on... Read more
23d
dna
Natco Pharma's stock jumps over 9% as partner MylanInc gets USFDA nod for cancer drugLLC, Bayer Healthcare Pharmaceuticals Inc and Onyx Pharmaceuticals Inc sell Sor
Natco Pharma's stock jumps over 9% as partner MylanInc gets USFDA nod for cancer drug
dna / Posted 23 days ago
LLC, Bayer Healthcare Pharmaceuticals Inc and Onyx Pharmaceuticals Inc sell Sorafenib tablets, 200mg under the brand name 'Nexavar' in the U S market, it added. "For the 12 months ending December 31, 2015, Nexavar had U S sales of approximately... Read more
2 related stories
23d
The Economic Times
Natco Pharma's partner MylanInc gets USFDA nod for cancer drugLLC, Bayer Healthcare Pharmaceuticals Inc and Onyx Pharmaceuticals Inc sell Sor
Natco Pharma's partner MylanInc gets USFDA nod for cancer drug
The Economic Times / Posted 23 days ago
LLC, Bayer Healthcare Pharmaceuticals Inc and Onyx Pharmaceuticals Inc sell Sorafenib tablets, 200mg under the brand name 'Nexavar' in the U S market, it added. "For the 12 months ending December 31, 2015, Nexavar had U S sales of approximately... Read more
2 related stories
23d
Business Standard India
Natco Pharma gains on tentative nod from USFDA for cancer drugsaid that its marketing partner, Mylan Inc., has received a US regulator tentat
Natco Pharma gains on tentative nod from USFDA for cancer drug
Business Standard India / Posted 23 days ago
said that its marketing partner, Mylan Inc., has received a US regulator tentative nod Sorafenib, the generic version of Nexavar. “Mylan Inc. has received a tentative approval for its abbreviated new drug application (ANDA) for Sorafenib... Read more
2 related stories

People in this news